Celltrion Launches CT-P59, an antibody preventive treatment for COVID-19


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Celltrion Launches CT-P59, an antibody preventive treatment for COVID-19
Celltrion launches post-exposure prophylaxis clinical trial of anti-COVID-19 monoclonal antibody treatment candidate, CT-P59

The Celltrion Group announced the launch of its Phase III clinical trial of CT-P59, a candidate anti-COVID-19 monoclonal antibody treatment as a preventive. The launch of the post-exposure prophylaxis clinical trial follows the approval of the Investigational New Drug Application (IND) by the Korean Ministry of Food Safety and Medicines on October 8, 2020.

Celltrion expects to recruit approximately 1,000 patients to assess prophylaxis for populations in contact with patients infected with SARS-CoV-2. The post-exposure prophylaxis clinical trial will assess the preventative effect and safety of CT-P59 and determine whether it can induce a neutralizing antibody response to block virus infection in human cells.

" We hope that anti-COVID-19 monoclonal antibodies like CT-P59 can offer people at high risk effective protection against COVID-19 and help prevent any further spread in the population," said Dr Sang Joon Lee, Senior Executive Vice President of Celltrion. " We look forward to continuing to generate data as this trial unfolds and we remain committed to fighting the spread of the virus around the world."

Celltrion has already shown promising safety results in Phase I clinical trial in healthy volunteers. The Korean Ministry of Food Safety and Medicines has now approved Celltrion's IND application to initiate a pivotal Phase II / III trial of this potential treatment in patients with mild to moderate symptoms.

Celltrion Healthcare is committed to providing innovative and affordable medicines to promote patient access to advanced therapies. Its products are manufactured in state-of-the-art mammalian cell culture sites, designed and manufactured in accordance with US FDA aGMP and EU GMP. Celltrion Healthcare strives to provide cost-effective and high-quality solutions through an extensive global network spanning over 110 countries.

Tags : #Celltrion #LatestNewsonCelltrion15thOct #LatestPharmaNews15thOct #DrSangJoonLeeofCeltrion #LatestNewsonCOVIDTreatment15thOct #KoreanMinistryofFoodSafetyandMedicines

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026